Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;50(10):8361-8372.
doi: 10.1007/s11033-023-08604-0. Epub 2023 Aug 24.

Non-coding RNA genes modulate PI3K/AKT signaling pathway in polycystic ovary syndrome

Heba S Omar  1 , Osama Ahmed Ibrahim  2 , Maha Gomaa Sayed  3 , Eman Mohammed Faruk  4 , Hanan Fouad  1   5 , Miriam Safwat  1
Affiliations

Non-coding RNA genes modulate PI3K/AKT signaling pathway in polycystic ovary syndrome

Heba S Omar et al. Mol Biol Rep. 2023 Oct.

Abstract

Background: The PI3K protein kinase B (PI3K/AKT) signaling pathway has crucial roles in insulin signaling and other endocrine disorders. The purpose of this study is to validate the association of PCOS with PI3K/AKT pathway target genes, miRNA486-5p, and miRNA483-5p as well as to evaluate the outcome of metformin on the pathogenesis of PCOS. METHODS: This case-controlled study included 3 subject groups: twenty healthy females (control group), twenty PCOS females before treatment, and twenty PCOS females treated with metformin at a dose (500 mg 3 times per day for 3 months). The following gene expressions were assessed by real-time PCR: PI3K, AKT, ERK, GLUT4, miRNA486-5p, and miRNA483-5p in the whole blood.

Results: There was a significant decrease in miRNA486-5p and miRNA483-5p in the PCOS group with a significant negative correlation between miRNA486-5p and PI3K and a significant negative correlation between miRNA483-5p and ERK. Metformin treatment resulted in significant elevation of the studied miRNA, significant downregulation of PI3K/AKT target genes, and significant amelioration of the gonadotrophic hormonal imbalance and insulin resistance markers: fasting blood glucose, HBA1C, fasting insulin, and GLUT4 gene expression.

Conclusions: miRNA486 and miRNA483 downregulation may contribute to the etiology of PCOS, influence glucose metabolism, and result in IR in PCOS. Metformin's upregulation of those miRNAs affects glucose metabolism by controlling the expression of GLUT4, ameliorates PCOS-related insulin resistance, and improves PCOS-related hormonal imbalance by controlling the PI3K/AKT signaling pathway.

Keywords: GLUT 4; PCOS; PI3K/AKT; miRNA 483; miRNA 486.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D (2019) Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci 228:167–175 - DOI - PubMed
    1. Escobar-Morreale HF (2018) Polycystic ovary syndrome: definition, etiology, diagnosis, and treatment. Nat Rev Endocrinol 14(5):270–284 - DOI - PubMed
    1. Wolf WM, Wattick RA, Kinkade ON, Olfert MD (2018) Geographical prevalence of polycystic ovary syndrome as determined by region and Race/Ethnicity. Int J Environ Res Public Health 15(11):2589 - DOI - PubMed - PMC
    1. Taits N, Vorobtsova IN, Kurdynko LV (2018) Pathophysiological aspects of the formation of insulin resistance in women with polycystic ovary syndrome. Med Theory Pract 3(2):19–25
    1. Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources